Related Experiment Video
Updated: Mar 19, 2026
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
High-resolution melting analysis for molecular detection of multidrug resistance tuberculosis in Peruvian isolates
Marco Galarza1, Manuel Fasabi1, Kelly S Levano1
1Laboratorio de Biotecnología y Biología Molecular, Instituto Nacional de Salud, Lima, Peru.
Background:
The emergence of multidrug-resistant strains is a major health problem especially for countries with high TB incidence such as Peru. In this study, we evaluated High Resolution Melting (HRM) assay in Peruvian isolates for the detection of mutations within rpoB, katG genes and promoter region inhA to determine isoniazid and rifampicin resistance in Mycobacterium tuberculosis (Mtb).
Methods:
DNA samples extracted from a total of 167 clinical isolates of Mtb, 89 drug-sensitive and 78 multidrug-resistant, were blindly analyzed by HRM analysis and verified by DNA sequencing.
Results:
The HRM analysis generated patterns that were specific to distinguish between sensitive and resistance isolates. The sensitivity and specificity of the HRM assays in comparison with drug susceptibility testing (DST) for detection of rifampicin resistance were 98.7 % and 97.5 %, and for isoniazid resistance were 98.7 % and 100 %.
Conclusion:
This study suggests that HRM Analysis could help with rapid diagnosis of MDR-TB cases in Peru.
Insights
High Resolution Melting (HRM) assay accurately detects multidrug-resistant tuberculosis (MDR-TB) in Peru. This rapid diagnostic tool identifies mutations linked to isoniazid and rifampicin resistance in Mycobacterium tuberculosis.
Area of Science:
- Microbiology
- Molecular Biology
- Public Health
Background:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health threat, particularly in high-incidence countries like Peru.
- The study addresses the urgent need for efficient diagnostic methods to combat MDR-TB.
- Genetic mutations in specific genes (rpoB, katG, inhA) are key indicators of drug resistance in Mycobacterium tuberculosis (Mtb).
Purpose of the Study:
- To evaluate the efficacy of the High Resolution Melting (HRM) assay for detecting drug resistance in Peruvian Mtb isolates.
- To identify mutations in the rpoB, katG genes, and inhA promoter region associated with isoniazid and rifampicin resistance.
- To assess the potential of HRM as a rapid diagnostic tool for MDR-TB in Peru.
Main Methods:
- DNA samples from 167 clinical Mtb isolates (89 drug-sensitive, 78 MDR) were analyzed.
- High Resolution Melting (HRM) assay was performed on all samples.
- Results were validated using DNA sequencing and compared with traditional drug susceptibility testing (DST).
Main Results:
- HRM analysis successfully differentiated between sensitive and resistant Mtb isolates.
- The assay demonstrated high sensitivity (98.7%) and specificity (97.5% for rifampicin resistance; 100% for isoniazid resistance) compared to DST.
- HRM identified specific mutation patterns linked to drug resistance.
Conclusions:
- High Resolution Melting (HRM) assay is a reliable and sensitive method for detecting isoniazid and rifampicin resistance in Mtb.
- HRM analysis shows promise as a rapid diagnostic tool for identifying MDR-TB cases in Peru.
- The findings support the implementation of HRM for improved MDR-TB surveillance and patient management in Peru.
